WRIB 2024

Lambda Therapeutic Research & Novum Pharmaceutical Research will be participating in the 18th WRIB (Workshops on Recent Issues in Bioanalysis) conference, scheduled from May 6-10, 2024, in San Antonio River Walk, TX, USA.

Don’t miss our Poster (#Day2-P02) presentation on “Singlicate well assay for the analysis of Enoxaparin Pharmacodynamic Biomarkers (Anti-Factor Xa, Anti-Factor IIa, and TFPI) for the Bioequivalence study” scheduled on 8th May.

Lambda & Novum offers an extensive suite of bioanalytical capabilities, specializing in cell-based assays, biomarkers, immunogenicity, and pharmacokinetics (PK). With cutting-edge facilities and a seasoned team of scientists, we deliver end-to-end solutions for analyzing small molecules, biomarkers, biologics, and therapeutic elemental drugs. Our team boasts extensive experience in developing validated methods for both generic and NCE molecules, including ultra-trace detection, endogenous, and chiral assays. Click here to know more about our Lab Capabilities.

Our experts Mr. Ravi Maurya & Ms. Cathy Lopez will be available to answer all your questions and discuss your study needs. For more information or to schedule a meeting during WRIB, please contact Cathy Lopez at [email protected].